Bloomberg Technology1 day ago
Scribe Bets on a New Era of Gene Editing
Dr. Jennifer Doudna won the Nobel Prize for pioneering gene-editing technology CRISPR. Today, Scribe Therapeutics, the company she co-founded, just raised $128.7 million in its IPO...
